OBO ID: CHEBI:170007 |
Term Name: | nirmatrelvir | Search Ontology: | |
---|---|---|---|
Synonyms: |
|
||
Definition: | An azabicyclohexane that is (1R,5S)-3-azabicyclo[3.1.0]hexane substituted by {(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}aminoacyl, 3-methyl-N-(trifluoroacetyl)-L-valinamide, methyl and methyl groups at positions 2S, 3, 6 and 6, respectively. It is the first orally administered inhibitor of SARS-CoV-2 main protease developed by Pfizer and used in combination with ritonavir for the treatment of COVID-19. | ||
References: |
|
||
Ontology: | ChEBI ( EBI ) |
PHENOTYPE
No data available